Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PF-1355

SKU: orb1304131

Description

PF-1355

Research Area

Product Categories/Products/Small Molecules,Metabolism

Images & Validation

−

Key Properties

−
CAS Number1435467-38-1
MW321.35
Purity99.77%
FormulaC14H15N3O4S
SMILESO=C1C=C(C=2C=C(OC)C=CC2OC)N(C(=S)N1)CC(=O)N

Bioactivity

−
In Vivo
Administering PF-1355 orally diminishes MPO activity in plasma, lessens vascular edema and neutrophil recruitment, and increases circulating cytokines levels. PF-1355 treatment entirely inhibits albuminuria and chronic renal dysfunction in a model of anti-glomerular basement membrane disease .
In Vitro
PF-1355 inhibits MPO activity in phorbol ester-stimulated human neutrophils as measured by taurine chlorination (EC50=1.47 μM) as well as lipopolysaccharide-treated human blood measuring residual MPO activity (EC50=2.03 μM) .

Storage & Handling

−
Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

−
  • PF-1355 [orb611931]

    [1435467-38-1]

    321.3516

    C14H15N3O4S

    1 g, 100 mg, 250 mg, 1 ml x 10 mm (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

−
No computed properties available.

Protocol Information

Available Sizes

Select a size below

500 mg
2 mg
$ 130.00
1 ml x 10 mm (in DMSO)
$ 150.00
5 mg
$ 150.00
10 mg
$ 180.00
25 mg
$ 220.00
50 mg
$ 330.00
100 mg
$ 430.00
200 mg
$ 560.00